ProQuest Associates IV LLC - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 48 filers reported holding MERSANA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
ProQuest Associates IV LLC ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$9,557,000
-44.0%
955,7090.0%18.05%
-31.3%
Q2 2018$17,069,000
+13.2%
955,7090.0%26.27%
+51.6%
Q1 2018$15,072,000
-4.0%
955,7090.0%17.33%
-16.9%
Q4 2017$15,702,000
-5.0%
955,7090.0%20.86%
+26.0%
Q3 2017$16,524,000
+23.8%
955,7090.0%16.55%
-3.0%
Q2 2017$13,351,000955,70917.07%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,005,600$54,396,0004.32%
Bain Capital Life Sciences Investors, LLC 3,695,667$50,187,0003.29%
COMMODORE CAPITAL LP 429,228$5,829,0002.03%
Ghost Tree Capital, LLC 450,000$6,111,0001.68%
Avoro Capital Advisors LLC 6,800,000$92,344,0001.61%
RHO CAPITAL PARTNERS INC 796,458$10,816,0000.99%
Rock Springs Capital Management LP 2,845,618$38,643,0000.76%
SILVERARC CAPITAL MANAGEMENT, LLC 125,123$1,699,0000.76%
HighVista Strategies LLC 59,906$814,0000.58%
Sio Capital Management, LLC 157,259$2,136,0000.53%
View complete list of MERSANA THERAPEUTICS INC shareholders